Skip to main content

Enviracor J-5

This page contains information on Enviracor J-5 for veterinary use.
The information provided typically includes the following:
  • Enviracor J-5 Indications
  • Warnings and cautions for Enviracor J-5
  • Direction and dosage information for Enviracor J-5

Enviracor J-5

This treatment applies to the following species:
Company: Zoetis

Escherichia Coli Bacterin

Enviracor J5 is recommended for use in healthy dairy cattle as an aid in the reduction of shedding of E. coli in the milk due to mastitis. For effective mastitis control this product should be used in conjunction with acceptable good management practices.

Directions For Use

Shake well. Three doses are required. Administer each 5-mL dose subcutaneously, one hand-width cranial to the shoulder. Vaccinate cows or heifers at 7 and 8 months of gestation followed by the third dose within two weeks postpartum.


Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not vaccinate within 60 days before slaughter. Local swelling occasionally occurs and may persist at the injection site. Contains thimerosal as a preservative. Do not mix with other products. In case of human exposure, contact a physician. In case of anaphylactoid reactions, epinephrine should be administered immediately.

Technical inquiries should be directed to Zoetis Inc. Technical Services, (888) 963-8471.

Mfd by: Poultry Health Laboratories (A Division of PHL Associates, Inc.), Davis, CA 95616

VLN 357/PCN 2648.00

Dist by: Zoetis Inc., Kalamazoo, MI 49007, USA




100 mL (20 doses)



250 mL (50 doses)



CPN: 3690348.4

Telephone:   269-359-4414
Customer Service:   888-963-8471
Every effort has been made to ensure the accuracy of the Enviracor J-5 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2022 Animalytix LLC. Updated: 2021-11-29